Please assess the completion status of the following clinical trial:

Trial Title: Acetaminophen vs Indomethacin in Treating hsPDA

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Gestational age at birth 22 weeks to 31 6/7 weeks.~* Birth weight ≤ 1500 grams~* Day of life ≤ 21 days~* ECHO findings:~Left-to-right ductal flow AND 2 of the following 3:~* Ductal size \> 1.5mm at smallest diameter~* Reversal of flow in descending aorta~* Left atrial size to aortic root ratio \>1.5~* Platelet count \> 50,000~Exclusion Criteria:~* Ductal dependent congenital heart disease~* Major congenital anomaly~* Life-threatening infection~* Urine output \< 1cc/kg/hr in prior 8 hours~* Serum creatinine \> 1.8 mg/dL~* Hyperbilirubinemia requiring exchange transfusion~* Active NEC Stage 2 or 3 using Bell's staging criteria~* Active intestinal perforation~* Liver dysfunction \[2x upper limit of normal for aspartate aminotransferase(AST) and/or alanine aminotransferase (ALT)\]~* Active GI bleeding~* Concurrent hydrocortisone use~* Known IVH Grade 3 or 4

- Gender: ALL
- Minimum Age: 22 Weeks
- Maximum Age: 32 Weeks
- Healthy Volunteers: f

Study Arms:
- Indomethacin (Type: ACTIVE_COMPARATOR): Indomethacin as drug to treat PDA.
- Acetaminophen (Type: EXPERIMENTAL): Acetaminophen as drug to treat PDA.

Based on this trial design, predict the completion outcome and termination type (if applicable).